Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803.

KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803. Clin Cancer Res. 2009 Dec 01; 15(23):7322-9.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.